Skip to page content
Power & PoliticsUnited States edition
Sections
Only your five-digit ZIP code is sent. We never ask for your address.
Independent · nonpartisan
Illustrative empty legislative chamber as neutral vote indicators resolve a recorded outcome
118th Congress · 2023–2025
S. 4635

Pharmaceutical Risk Assessment and Mitigation Act of 2024

Armed Forces and National Security Senate 1 cosponsors
Latest action: Read twice and referred to the Committee on Armed Services. · July 8, 2024
Understand the measure

What this bill does

No official summary is on file here yet. Check Congress.gov for available summaries and the bill text.

Check official summaries ↗

01
The measure

The official bill title and text published by Congress and GovInfo.

02
The movement

Every committee, chamber, and clerk-recorded action attached to its date.

03
The votes

Every roll call on this measure, or a notice when no individual vote exists.

Where it stands

The measure's progress

In committee

Read twice and referred to the Committee on Armed Services.

Recorded July 8, 2024, as the clerk wrote it

Sponsor Sen. Peters, Gary C. [D-MI]
Committee Armed Services Committee
Recorded votes None taken
The official record
Cite this record
Reference number
bill-118-s4635
Official source
Congress.gov ↗
Last checked
Status and actions last read from the official GovInfo BILLSTATUS record
AP style

Power & Politics, "S. 4635 (118th Congress): Pharmaceutical Risk Assessment and Mitigation Act of 2024," last checked Oct. 11, 2026, citing Congress.gov, https://powerandpolitics.co/cite/bill-118-s4635

APA

Power & Politics. (2026, October 11). S. 4635 (118th Congress): Pharmaceutical Risk Assessment and Mitigation Act of 2024 [Bill record]. Retrieved November 5, 2026, from https://powerandpolitics.co/cite/bill-118-s4635

Chicago

Power & Politics. "S. 4635 (118th Congress): Pharmaceutical Risk Assessment and Mitigation Act of 2024." Last modified October 11, 2026. Accessed November 5, 2026. https://powerandpolitics.co/cite/bill-118-s4635.

BibTeX
@misc{votefiles_bill_118_s4635,
  author       = {{Power & Politics}},
  title        = {{S. 4635 (118th Congress): Pharmaceutical Risk Assessment and Mitigation Act of 2024}},
  year         = {2026},
  howpublished = {\url{https://powerandpolitics.co/cite/bill-118-s4635}},
  note         = {Reference number bill-118-s4635; official source: Congress.gov, https://www.congress.gov/bill/118th-congress/senate-bill/4635; last checked October 11, 2026; accessed November 5, 2026}
}
Plain link

https://powerandpolitics.co/cite/bill-118-s4635

Cite the official source for the underlying fact. Power & Politics reference number never changes for this record. AP, APA and Chicago are standard citation styles for news and academic writing, and BibTeX is the format reference-manager programs read.

Official analyses

CBO cost estimates and CRS reports on S. 4635

No official record has been found at this time. We are watching for updates.

Listed only where the Congressional Budget Office names this bill number in its estimate's title and that title matches the bill's own, or where the Congressional Research Service lists this bill among a report's related materials. Titles and dates are the publishers' own. All watchdog and scorekeeper reports

Official records

No recorded vote

No roll call has been taken on this measure, so no member's position on it is on the record. Most measures never get one.